A novel serum protein signature associated with resistance to epidermal growth factor receptor tyrosine kinase inhibitors in head and neck squamous cell carcinoma.
about
Noninvasive Imaging of Cycling Hypoxia in Head and Neck Cancer Using Intrinsic Susceptibility MRI.The quest to overcome resistance to EGFR-targeted therapies in cancer.Acquired resistance to EGFR tyrosine kinase inhibitors alters the metabolism of human head and neck squamous carcinoma cells and xenograft tumours.Three-dimensional (3D) tumor spheroid invasion assay.
P2860
A novel serum protein signature associated with resistance to epidermal growth factor receptor tyrosine kinase inhibitors in head and neck squamous cell carcinoma.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
A novel serum protein signatur ...... neck squamous cell carcinoma.
@en
A novel serum protein signatur ...... neck squamous cell carcinoma.
@nl
type
label
A novel serum protein signatur ...... neck squamous cell carcinoma.
@en
A novel serum protein signatur ...... neck squamous cell carcinoma.
@nl
prefLabel
A novel serum protein signatur ...... neck squamous cell carcinoma.
@en
A novel serum protein signatur ...... neck squamous cell carcinoma.
@nl
P2093
P1476
A novel serum protein signatur ...... neck squamous cell carcinoma.
@en
P2093
Alexis De Haven Brandon
Anna Wilkins
Gary M Box
Kevin J Harrington
Marta Mendiola
Melanie Valenti
Sharon Gowan
Susanne J Rogers
Suzanne A Eccles
P304
P356
10.1016/J.EJCA.2013.03.011
P577
2013-04-10T00:00:00Z